38: Does remifentanil cause opioid-induced hy...
Up next
Recommended Episodes
Join Dr. Jerry Yoo as he sits down with Dr. Tom Buchheit, Director of the Regenerative Pain Therapies Program at Duke University. In this episode, Dr. Buchheit shares insights into how regenerative medicine and regenerative physical therapy can potentially spare individuals f ...
Diuretic therapy in HFrEF, AF ablation, TACT 2 and the story of subgroups, and SGLT2 inhibitor underuse are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare professionals only. To read a partial tran ...
Immune checkpoint inhibitors can significantly improve cancer survival rates. But resulting immune-related toxicities are common, requiring multidisciplinary cooperation between oncology and neurology. This episode, PN's podcast editor Dr. Amy Ross Russell speaks with ...